News

Eli Lilly and Company announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. The tender offer for all outstanding shares of common stock of CoLucid, at…
Read More...

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its licensee for RGN-137,…
Read More...

Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases, and…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products announced it has signed a definitive agreement to divest its rights to the royalty stream from…
Read More...

Ligand Pharmaceuticals announces the completion of enrollment in the Company’s Phase 2 clinical trial with its novel, small-molecule glucagon receptor antagonist LGD-6972 for the…
Read More...

Intellipharmaceutics International, a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral…
Read More...

Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights to develop, manufacture and…
Read More...

Sanofi and Lonza announced that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in…
Read More...

ANI Pharmaceuticals, Inc. announced that it has acquired Inderal XL from Cranford Pharmaceuticals, LLC and InnoPran XL  from Holmdel Pharmaceuticals LP. The acquired assets include the…
Read More...

Swiss drugmaker Novartis's drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a…
Read More...

Cyclacel Pharmaceuticals Inc said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a late-stage study. The drug developer's stock…
Read More...

Finch Therapeutics, Inc., a microbiome therapeutics company, and OpenBiome, a leading public stool bank announced a collaboration to develop FIN-403, an orally administered microbial…
Read More...

Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial…
Read More...

Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced that it has entered into a collaboration with Frenova Renal…
Read More...

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today…
Read More...

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an…
Read More...

Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose…
Read More...

Valeant Pharmaceuticals International, Inc. and EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating…
Read More...

Abzena has entered into a manufacturing agreement with University College London (UCL). Under the agreement, Abzena will manufacture Magacizumab, an antibody created using the…
Read More...

Xbrane Biopharma has been granted GMP (Good Manufacturing Practice) certification for its Spherotide production facility by AIFA, the Italian Medicines Agency. The GMP certification…
Read More...